Zobrazeno 1 - 6
of 6
pro vyhledávání: '"R. M. Velieva"'
Autor:
E. G. Skorodumova, O. A. Rubanenko, A. O. Rubanenko, S. T. Enginoev, M. A. Kercheva, E. L. Zaslavskaya, E. V. Efremova, E. Yu. Gubareva, I. N. Lyapina, R. M. Velieva, E. A. Skorodumova, A. V. Siverina
Publikováno v:
Российский кардиологический журнал, Vol 29, Iss 1S (2024)
Aim. To compare the effectiveness and safety of direct oral anticoagulants (DOACs) with a vitamin K antagonist (VKA) in patients with atrial fibrillation (AF) and stage 4 and 5 chronic kidney disease (CKD).Material and methods. We searched in the Pub
Externí odkaz:
https://doaj.org/article/31b7b020b21d4e9c9d9bf98476330d73
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 16, Iss 6, Pp 1024-1030 (2020)
Today, optimal duration of double antiplatelet (DAPT) and triple antithrombotic therapy (TATT) in patients with acute coronary syndrome (ACS) remains the subject of scientific and practical discussion on possibilities of ischemic and hemorrhagic risk
Externí odkaz:
https://doaj.org/article/602f6b8481d94820a0e0f9085a209021
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 15, Iss 6, Pp 806-812 (2020)
Aim. We aimed to study in real clinical practice the clinical and anamnestic characteristics, the peculiarities of double antiplatelet therapy (DAPT) prescription as well the incidence of ischemic and hemorrhagic events in patients with ST-elevated m
Externí odkaz:
https://doaj.org/article/00e6e0014905429e9b6154eded9d9954
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 16, Iss 6, Pp 1024-1030 (2020)
Today, optimal duration of double antiplatelet (DAPT) and triple antithrombotic therapy (TATT) in patients with acute coronary syndrome (ACS) remains the subject of scientific and practical discussion on possibilities of ischemic and hemorrhagic risk
Publikováno v:
Racionalʹnaâ Farmakoterapiâ v Kardiologii, Vol 15, Iss 6, Pp 806-812 (2020)
Aim.We aimed to study in real clinical practice the clinical and anamnestic characteristics, the peculiarities of double antiplatelet therapy (DAPT) prescription as well the incidence of ischemic and hemorrhagic events in patients with ST-elevated my
Autor:
A. German, A. N. Kokov, R. M. Velieva, Vasiliy V. Kashtalap, N Fedorova, E Zhuravleva, Olga Gruzdeva, T. B. Pecherina, Olga Barbarash
Publikováno v:
European Heart Journal. 39